Faster, cheaper scan for prostate cancer on the way as experts say new test could mean thousands more men are tested every year
Experts predict it will change clinical practice, catching more cases early and paving the way for thousands more men to be tested each year. (Source: the Mail online | Health)
Source: the Mail online | Health - April 5, 2024 Category: Consumer Health News Source Type: news
Bracing for a Surge in Prostate Cancer Diagnoses
(MedPage Today) -- Driven by increased life expectancy and related changes in age structure, global prostate cancer cases will more than double over the next 15 years, a panel of experts concluded.
The number of new cases will increase from 1... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 5, 2024 Category: American Health Source Type: news
Integration of MRI Screening Beneficial for Prostate Cancer
FRIDAY, April 5, 2024 -- Integrating magnetic resonance imaging (MRI) into prostate cancer (PCa) screening is associated with a reduction in unnecessary biopsies and overdiagnosis of insignificant disease, according to a review published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2024 Category: Pharmaceuticals Source Type: news
Number of Prostate Cancer Cases Set to Increase to 2.9 Million in 2040
FRIDAY, April 5, 2024 -- The number of new prostate cancer cases is set to increase to 2.9 million in 2040, according to a study published online April 4 in The Lancet.
Nicholas D. James, M.B.B.S., Ph.D., from the Institute of Cancer Research in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2024 Category: Pharmaceuticals Source Type: news
Prostate cancer cases to double between 2020 and 2040, deaths to rise by 85 per cent: Lancet study
The commission called for evidence-based interventions, including early detection and diagnosis, along with education and awareness programmes, to help save lives from prostate cancer in the coming years. (Source: The Economic Times)
Source: The Economic Times - April 5, 2024 Category: Consumer Health News Source Type: news
Prostate Cancer Tsunami Coming, Experts Caution Prostate Cancer Tsunami Coming, Experts Caution
A Lancet commission is predicting an 85% increase in deaths from the disease by 2040.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 5, 2024 Category: Cancer & Oncology Tags: Urology Source Type: news
Prostate cancer rise sparks calls for overhaul of testing
Research forecasts global deaths from the disease will almost double in 20 years (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 4, 2024 Category: Pharmaceuticals Source Type: news
Prostate cancer cases worldwide likely to double by 2040, analysis finds
Largest study of its kind predicts 85% increase in deaths from the disease in same period as more men live longerThe number of men diagnosed with prostate cancer worldwide is projected to double to 2.9 million a year by 2040, with annual deaths predicted to rise by 85%, according to the largest study of its kind.Prostate cancer is already a major cause of death and disability, and themost common form of male cancer in more than 100 countries. But with populations ageing and life expectancy rising globally, a new analysis forecasts a dramatic surge in cases and deaths over the next 15 years.Continue reading... (Source: Guar...
Source: Guardian Unlimited Science - April 4, 2024 Category: Science Authors: Andrew Gregory Health editor Tags: Prostate cancer Health Cancer research Society World news Medical research Men's health Source Type: news
RLS enters strategic agreement with Eckert & Ziegler
RLS Radiopharmacies has entered a strategic agreement with Eckert & Ziegler, which will see all 31 of RLS’s radiopharmacies equipped with Eckert & Ziegler’s GalliaPharm generators.
The RLS radiopharmacy network will use these generators to produce gallium-68-based (Ga-68) radiopharmaceuticals for PET imaging and treatment planning for patients with neuroendocrine tumors and prostate cancer.
To date, RLS has installed Eckert & Ziegler’s GalliaPharm generators within most of its locations and anticipates the remaining radiopharmacies will be operational by the end of June 2024.
RLS added that it is also building ...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
The rise of theranostics: Part 2 -- Moving into communities
A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. That has changed and the field of theranostics is expanding rapidly in various ways, as described in part 1 of AuntMinnie.com's series on the rise of theranostics.
However, few freestanding theranostics centers exist today. Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. They're also mindful of the multiple dedicated teams required to build a thera...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: Liz Carey Tags: Practice Management Radiation Oncology/Therapy Nuclear Medicine Medicolegal Genitourinary Radiology Source Type: news
Hoag launches Pylarify PET prostate cancer trial
Hoag healthcare system in Orange County, CA, has launched a clinical trial to assess the prostate cancer PET imaging radiotracer Pylarify in patients newly diagnosed with intermediate disease.
Currently, the radiotracer is approved in the U.S. for diagnosed prostate cancer patients to identify suspected metastasis or recurrence of the disease. The trial will use Pylarify with whole-body PET/CT scans in men with favorable intermediate prostate cancer, including Gleason Score 3+4 tumors, Hoag said.
The phase IV open-label multicenter trial will ultimately assess the safety and accuracy of the approach in an estimated 274 p...
Source: AuntMinnie.com Headlines - April 3, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
MRI + Blood Test Results May Cut Unnecessary Biopsies for Prostate Cancer
TUESDAY, April 2, 2024 -- Prostate biopsies may not be necessary for patients with equivocal or negative magnetic resonance imaging (MRI) results and low prostate-specific antigen density (PSAD), according to a study published online March 29... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 2, 2024 Category: Pharmaceuticals Source Type: news
New Trials in Prostate Cancer: Could Your Patient Benefit? New Trials in Prostate Cancer: Could Your Patient Benefit?
Perhaps one of your patients could benefit from a clinical trial that has recently opened in prostate cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 2, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Some Cancer Patients Can Find It Hard to Tell Family and Friends
(MedPage Today) -- Ever since Anthony Bridges found out he had prostate cancer 6 years ago, he hasn't stopped talking about it. He told his Facebook friends immediately.
Now, the 68-year-old man from Georgia spends time working with others to... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 31, 2024 Category: Hematology Source Type: news
Cancer signs could be spotted years before symptoms, says new research institute
Tests that can identify early changes in cells would give doctors more time to offer treatment, say Cambridge researchersScientists at a recently opened cancer institute at Cambridge University have begun work that is pinpointing changes in cells many years before they develop into tumours. The research should help design radically new ways to treat cancer, they say.TheEarly Cancer Institute– which has just received £11m from an anonymous donor – is focused on finding ways to tackle tumours before they produce symptoms. The research will exploit recent discoveries which have shown that many people develop precancerous...
Source: Guardian Unlimited Science - March 31, 2024 Category: Science Authors: Robin McKie Science Editor Tags: Cancer research Medical research Health Science Society Health policy Prostate cancer University of Cambridge UK news Source Type: news
